Filing Flows › Chemed (CHE) › Q4 2025
Chemed (CHE) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Feb 27, 2026
Chemed (CHE) reported revenue of $639M for the fourth quarter 2025 (Q4 2025), -0.1% from a year earlier and +2% from the quarter before. Operating margin was 15.7%, net earnings $76.8M (12.0% of revenue).
Chemed, Q4 2025: revenue $639M (-0.1% year over year), operating margin 15.7%, net earnings $76.8M, operating cash flow $134M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $639M | +2% | -0.1% |
| Operating profit | $101M | +35% | -12% |
| Net earnings | $76.8M | +19% | -15% |
| Operating cash flow | $134M | +60% | -19% |
| Free cash flow | $117M | +77% | -23% |
What changed
Revenue was $639.3M in Q4 2025, roughly flat year over year and up 2% from the previous quarter. VITAS was the largest line at 65% of revenue.
Operating profit was $100.7M, a 15.7% margin (down 2.1 points year over year). Total costs grew 2% against flat revenue. Net earnings were $76.8M, down 15% year over year. The effective tax rate was 27.2%.
Operating cash flow was $133.5M (down 19% year over year), 174% of net earnings. Non-cash charges added back $16.3M of depreciation and amortization. Working capital and other items added $40.5M. Capital expenditures of $16.8M left free cash flow of $116.8M.
Questions
What was Chemed's revenue in the fourth quarter 2025?
Chemed (CHE) reported revenue of $639M for the fourth quarter 2025 (Q4 2025), -0.1% from a year earlier and +2% from the quarter before.
Was Chemed profitable in the fourth quarter 2025?
Operating profit was $101M (15.7% of revenue) and net earnings $76.8M.
Source: Chemed 10-K on SEC EDGAR.